Ameritas Advisory Services LLC Takes Position in Humana Inc. $HUM

Key Points

• Ameritas Advisory Services purchased 4,302 Humana shares worth approximately $1.71 million in the second quarter. Institutional investors now own 92.38% of the company.
• Analyst sentiment is mixed: 14 analysts rate Humana a Buy, 15 a Hold and one a Sell, resulting in a consensus Hold rating and a $403.91 target price.
• Humana beat quarterly earnings expectations with $7.61 in EPS and $40.89 billion in revenue, while revenue increased 26.2% year over year. The company also declared a quarterly dividend of $0.885 per share, equal to a 0.9% annualized yield.

Ameritas Advisory Services LLC purchased a new position in Humana Inc. (NYSE:HUM - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,302 shares of the insurance provider's stock, valued at approximately $1,709,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Johnson Financial Group Inc. purchased a new position in Humana in the second quarter worth $26,000. Fideuram Asset Management Ireland dac purchased a new stake in shares of Humana in the 4th quarter valued at $27,000. Trust Co. of Vermont acquired a new stake in Humana during the second quarter worth about $28,000. Reflection Asset Management purchased a new position in Humana during the fourth quarter valued at approximately $29,000. Finally, Bogart Wealth LLC increased its stake in shares of Humana by 192.0% in the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on HUM shares. Raymond James Financial cut shares of Humana from an "outperform" rating to a "market perform" rating in a research note on Thursday, July 30th. Needham & Company LLC started coverage on shares of Humana in a report on Wednesday, May 20th. They issued a "buy" rating for the company. Wells Fargo & Company raised shares of Humana from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $227.00 to $502.00 in a research note on Monday, July 13th. Cantor Fitzgerald restated a "neutral" rating on shares of Humana in a report on Friday, September 4th. Finally, UBS Group initiated coverage on Humana in a research report on Thursday, July 30th. They issued a "buy" rating for the company. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $403.91.

Humana Stock Down 0.5%

Shares of NYSE HUM opened at $401.06 on Thursday. The firm has a market cap of $48.16 billion, a price-to-earnings ratio of 37.94, a PEG ratio of 2.64 and a beta of 0.74. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The business's 50 day moving average is $388.61 and its two-hundred day moving average is $301.31.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts' consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to analysts' expectations of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.Humana's revenue for the quarter was up 26.2% on a year-over-year basis. During the same period last year, the business posted $6.27 EPS. Research analysts predict that Humana Inc. will post 9 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana's dividend payout ratio is currently 33.49%.

About Humana

Humana Inc NYSE: HUM is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.